New Clinical Data Point to Use of GlycoMark as Biomarker of SGLT-2 Diabetes Drug Effectiveness and Compliance
RALEIGH, N.C., Oct. 30, 2023 /PRNewswire/ -- Precision Diabetes, Inc. announces new studies that show that the GlycoMark blood test, which measures
United States Aveon Health Scottsdale Precision Diabetes Inc American Diabetes Association Precision Diabetes Scientific Sessions
Source: thailand-business-news.com